Magnetic Resonance Spectroscopy in psychiatry;Magneticka Rezonancni Spektroskopie v psychiatrii

Psychiatrie

Volumn 4, Issue 2, 2000, Pages 116-119

  Hajek, T ^a   Spaniel, F ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

1H Magnetic Resonance Spectroscopy; 31P Magnetic Resonance Spectroscopy; Affective disorder; Anxiety Disorder; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; NEUROTRANSMITTER;

BRAIN; BRAIN METABOLISM; CZECH REPUBLIC; HUMAN; IMAGING; MENTAL DISEASE; NEUROCHEMISTRY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SCHIZOPHRENIA;

EID: 0033709325     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects
2. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging
3. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
4. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological phenotype
5. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia
6. Eelektromagneticke zobrazovaci systemy v medicine
7. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia
8. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic
9. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects
10. 31 Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia
11. Abnormal frontal lobe phos-phorous metabolism in bipolar disorder
12. Decreased left frontal lobe N-acetylaspartate in schizophrenia
13. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy
14. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum
15. Cell loss in the hippocampus of schizophrenics
16. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
17. Magnetic resonance spectroscopy in psychiatry: Basic principles and applications
18. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging
19. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms
20. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders
21. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy
22. 31P MRS
23. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder
24. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia
25. Functional magnetic resonance imaging (fMRI) for the psychiatrist
26. Chemical and physiologic brain imaging in schizophrenia
27. Proton magnetic resonance spectroscopy: An in vivo method of estimating hippocampal neuronal depletion in schizophrenia
28. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness
29. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy
30. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease
31. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis
32. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients
33. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia
34. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy
35. 31 Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics